Bioventus (BVS) Non-Current Assets (2020 - 2026)
Bioventus' (BVS) quarterly Non-Current Assets came in at $400.7 million in Q1 2026, down 9.35% YoY from $442.0 million in Q1 2025, and down 2.43% on a QoQ basis from $410.7 million in Q4 2025.
Bioventus (BVS) Non-Current Assets (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Non-Current Assets data on file, last reported at $400.7 million in Q1 2026.
- Quarterly Non-Current Assets fell 9.35% year-over-year to $400.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 10.0% YoY) and the FY2025 annual result came in at $410.7 million, down 9.2% from the prior year.
- Non-Current Assets slipped to $400.7 million in Q1 2026, from $410.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.1 billion in Q4 2022 to a low of $400.7 million in Q1 2026.
- A 5-year average of $612.4 million and a median of $528.3 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 175.73% — and 2023, when it sank 50.65%.
- Tracing BVS's Non-Current Assets over 5 years: stood at $1.1 billion in 2022, then slumped by 50.65% to $542.9 million in 2023, then slipped by 16.68% to $452.3 million in 2024, then slipped by 9.2% to $410.7 million in 2025, then declined by 2.43% to $400.7 million in 2026.
- The last three Non-Current Assets figures came in at $400.7 million (Q1 2026), $410.7 million (Q4 2025), and $420.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 415.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 415.82 Mn |
| Mar 28, 2026 | 400.73 Mn |
| Dec 31, 2025 | 410.72 Mn |
| Sep 27, 2025 | 420.69 Mn |
| Jun 28, 2025 | 431.59 Mn |
| Mar 29, 2025 | 442.05 Mn |
| Dec 31, 2024 | 452.35 Mn |
| Sep 28, 2024 | 470.80 Mn |
| Jun 29, 2024 | 483.29 Mn |
| Mar 30, 2024 | 528.34 Mn |
| Dec 31, 2023 | 542.91 Mn |
| Sep 30, 2023 | 561.65 Mn |
| Jul 1, 2023 | 576.32 Mn |
| Apr 1, 2023 | 578.74 Mn |
| Dec 31, 2022 | 1.10 Bn |
| Oct 1, 2022 | 1.13 Bn |
| Jul 2, 2022 | 931.62 Mn |
| Apr 2, 2022 | 951.74 Mn |
| Dec 31, 2021 | 962.76 Mn |
| Oct 2, 2021 | 408.71 Mn |